Blockchain Registration Transaction Record

Tonix to Present TNX-801 Mpox Vaccine Data at World Vaccine Congress Europe

Tonix Pharmaceuticals to present TNX-801 mpox vaccine data at World Vaccine Congress Europe 2026. Learn about this investigational platform and Tonix's pipeline.

Tonix’s participation at the World Vaccine Congress Europe underscores the company’s commitment to advancing innovative vaccine platforms for infectious diseases like mpox, which remains a global health concern. The TNX-801 platform, based on horsepox virus, represents a novel approach that could offer advantages over existing vaccines. Positive data could position Tonix as a key player in the vaccine market, potentially attracting investors and partners. Moreover, the company’s diverse pipeline, including treatments for fibromyalgia, depression, and rare diseases, highlights its broader impact on patient care. For investors, this event could be a catalyst for TNXP stock, while for the public, it signals progress toward new tools to combat infectious diseases.